Sinopharm Group Co. Ltd. (HKG:1099)

Sinopharm Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	61,571	66,470	63,817	61,914	52,926	58,856
Market Cap Growth	-6.71%	4.16%	3.08%	16.98%	-10.07%	-30.29%
Enterprise Value	164,762	178,877	158,985	148,432	150,328	130,433
Last Close Price	19.73	20.48	18.81	17.62	14.38	15.48
PE Ratio	7.96	8.86	6.40	6.42	5.56	6.90
Forward PE	7.15	7.01	5.82	6.05	4.93	6.48
PS Ratio	0.10	0.11	0.10	0.10	0.08	0.11
PB Ratio	0.43	0.49	0.48	0.50	0.43	0.55
P/TBV Ratio	0.78	0.89	0.90	0.95	0.84	1.08
P/FCF Ratio	2.97	6.20	3.81	2.91	5.96	5.35
P/OCF Ratio	2.79	5.41	3.37	2.61	4.63	4.44
PEG Ratio	1.57	0.87	0.58	0.66	0.43	0.43
EV/Sales Ratio	0.26	0.29	0.24	0.24	0.24	0.24
EV/EBITDA Ratio	6.50	8.42	5.91	5.30	5.35	5.26
EV/EBIT Ratio	8.10	9.43	6.47	5.77	5.84	5.75
EV/FCF Ratio	7.95	16.68	9.49	6.97	16.93	11.86
Debt / Equity Ratio	0.63	0.60	0.61	0.63	0.69	0.76
Debt / EBITDA Ratio	3.79	3.42	2.78	2.60	2.76	3.04
Debt / FCF Ratio	4.39	7.58	4.85	3.69	9.45	7.40
Asset Turnover	-	1.51	1.60	1.58	1.61	1.57
Inventory Turnover	-	8.83	9.06	8.98	9.68	9.28
Quick Ratio	1.07	1.06	1.06	0.99	1.01	0.99
Current Ratio	1.35	1.39	1.40	1.36	1.33	1.31
Return on Equity (ROE)	-	8.44%	13.03%	13.68%	13.78%	14.50%
Return on Assets (ROA)	-	2.87%	3.73%	4.06%	4.06%	4.11%
Return on Capital (ROIC)	-	5.61%	7.46%	8.18%	8.03%	8.22%
Return on Capital Employed (ROCE)	12.20%	12.50%	15.70%	17.50%	18.10%	17.80%
Earnings Yield	12.56%	11.29%	15.63%	15.57%	17.99%	14.50%
FCF Yield	33.66%	16.13%	26.26%	34.39%	16.78%	18.68%
Dividend Yield	3.89%	3.53%	5.10%	5.26%	6.40%	5.29%
Payout Ratio	10.73%	38.51%	28.26%	27.45%	27.75%	25.95%
Buyback Yield / Dilution	0.36%	-	-0.12%	0.12%	-0.30%	-4.70%
Total Shareholder Return	4.25%	3.53%	4.98%	5.38%	6.10%	0.60%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.